The Trypanosoma cruzi Satellite DNA OligoC-TesT and Trypanosoma cruzi Kinetoplast DNA OligoC-TesT for Diagnosis of Chagas Disease: A Multi-cohort Comparative Evaluation Study

PLoS Neglected Tropical Diseases

Volumn 8, Issue 1, 2014, Pages 55-

  De Winne, Koen ^a   Büscher, Philippe ^a   Luquetti, Alejandro O ^b   Tavares, Suelene B N ^b   Oliveira, Rodrigo A ^b   Solari, Aldo ^c   Zulantay, Ines ^c   Apt, Werner ^c   Diosque, Patricio ^d   Monje Rumi, Mercedes ^d   Gironès, Nuria ^e   Fresno, Manuel ^e   Lopez Velez, Rogelio ^f   Perez Molina, José A ^f   Monge Maillo, Begoña ^f   Garcia, Lineth ^g   Deborggraeve, Stijn ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^c UNIVERSITY OF CHILE   (Chile)

^d Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^e UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^f HOSPITAL RAMÓN Y CAJAL   (Spain)

^g UNIVERSIDAD MAYOR DE SAN SIMÓN   (Bolivia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD SAMPLING; CHAGAS DISEASE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KINETOPLAST DNA OLIGOC TEST; MAJOR CLINICAL STUDY; MALE; MCNEMAR TEST; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; SATELLITE DNA OLIGOC TEST; SENSITIVITY AND SPECIFICITY; TRYPANOSOMA CRUZI; ADOLESCENT; AFRICA; AGED; COHORT ANALYSIS; COMPARATIVE STUDY; EVALUATION STUDY; GENETICS; ISOLATION AND PURIFICATION; METHODOLOGY; MIDDLE AGED; MOLECULAR DIAGNOSIS; PARASITOLOGY; SOUTH AMERICA; YOUNG ADULT;

KINETOPLAST DNA; SATELLITE DNA;

ADOLESCENT; ADULT; AFRICA; AGED; CHAGAS DISEASE; COHORT STUDIES; DNA, KINETOPLAST; DNA, SATELLITE; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; PARASITOLOGY; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SOUTH AMERICA; TRYPANOSOMA CRUZI; YOUNG ADULT;

EID: 84893715916     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002633     Document Type: Article

References (23)

1. World Health Organization (2010) Chagas disease (American trypanosomiasis) fact sheet (revised in June 2010). Wkly Epidemiol Rec 34: 334-336.
2. Schmunis GA, Yadon ZE, (2010) Chagas disease: a Latin American health problem becoming a world health problem. Acta Trop 115: 14-21.
3. Coura JR, Junqueira ACV, Fernandes O, Valente SVA, Miles MA, (2002) Emerging Chagas disease in Amazonian Brazil. Trends Parasitol 18: 171-176.
4. Higuchi ML, Benvenuti LA, Martins Reis M, Metzger M, (2003) Pathophysiology of the heart in Chagas' disease: current status and new developments. Cardiovasc Res 60: 96-107.
5. Zingales B, Andrade SG, Briones MRS, et al. (2009) A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI. Mem Inst Oswaldo Cruz 104: 1051-1054.
6. Luquetti AO, Schmuñis GA. (2010) Diagnosis of Trypanosoma cruzi Infection. In: Telleria J, Tibayrenc M, editors. American trypanosomiasis: Chagas disease One Hundred Years of Research. Amsterdam: Elsevier. 743-792.
7. World Health Organization (2002) Control of Chagas disease. WHO Technical Report Series 905: 1-99.
8. Corredor Arjona A, Alvarez Moreno CA, Agudelo CA, et al. (1999) Prevalence of Trypanosoma cruzi and Leishmania chagasi infection and risk factors in a Colombian indigenous population. Rev Inst Med Trop Sao Paulo 41: 229-234.
9. Cuba CA, (1998) Review of the biologic and diagnostic aspects of Trypanosoma (Herpetosoma) rangeli. Rev Soc Bras Med Trop 31: 207-220.
10. Virreira M, Torrico F, Truyens C, et al. (2003) Comparison of polymerase chain reaction methods for reliable and easy detection of congenital Trypanosoma cruzi infection. Am J Trop Med Hyg 68: 574-582.
11. Sánchez G, Coronado X, Zulantay I, et al. (2005) Monitoring the efficacy of specific treatment in chronic Chagas disease by polymerase chain reaction and flow cytometry analysis. Parasite 12: 353-357.
12. Russomando G, de Tomassone MMC, de Guillen I, et al. (1998) Treatment of congenital Chagas' disease diagnosed and followed up by the polymerase chain reaction. Am J Trop Med Hyg 59: 487-491.
13. Schijman AG, Bisio M, Orellana L, et al. (2011) International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients. PLoS Negl Trop Dis 5: e931.
14. Deborggraeve S, Coronado X, Solari A, et al. (2009) T. cruzi OligoC-TesT: a simplified and standardized polymerase chain reaction format for the diagnosis of Chagas disease. PLoS Negl Trop Dis 3: e450.
15. Sloof P, Bos JL, Konings AFJM, et al. (1983) Characterization of satellite DNA in Trypanosoma brucei and Trypanosoma cruzi. J Mol Biol 167: 1-21.
16. Elias MCQB, Vargas NS, Zingales B, Schenkman S, (2003) Organization of satellite DNA in the genome of Trypanosoma cruzi. Mol Biochem Parasitol 129: 1-9.
17. Brenière SF, Bosseno MF, Barnabé C, Urdaneta-Morales S, Tibayrenc M, (1993) Copy number differences in the 195 bp repeated satellite DNA from Trypanosoma cruzi and Trypanosoma rangeli: potential use for epidemiologic surveys. Mem Inst Oswaldo Cruz 88: 163-165.
18. Brasil PE, De Castro L, Hasslocher-Moreno AM, Sangenis LH, Braga JU, (2010) ELISA versus PCR for diagnosis of chronic Chagas disease: systematic review and meta-analysis. BMC Infect Dis 10: 337.
19. Castro C, Prata A, (2000) Absence of both circadian rhythm and Trypanosoma cruzi periodicity with xenodiagnosis in chronic chagasic individuals. Rev Soc Bras Med Trop 33: 427-430.
20. Galvão LMC, Chiari E, Macedo AM, Luquetti AO, Silva SA, Andrade AL, (2003) PCR assay for monitoring Trypanosoma cruzi parasitemia in childhood after specific chemotherapy. J Clin Microbiol 41: 5066-5070.
21. Kocher TD, Thomas WK, Meyer A, et al. (1989) Dynamics of mitochondrial DNA evolution in animals: amplification and sequencing with conserved primers. Proc Natl Acad Sci USA 86: 6296-6200.
22. Moreira OC, Ramírez JD, Velázquez E, et al. (2013) Towards the establishment of a consensus real-time qPCR to monitor Trypanosoma cruzi parasitemia in patients with chronic Chagas disease cardiomyopathy: a substudy from the BENEFIT trial. Acta Trop 125: 23-31.
23. Zingales B, Miles MA, Campbell DA, et al. (2012) The revised Trypanosoma cruzi subspecific nomenclature: Rationale, epidemiological relevance and research applications. Infect Genet Evol 12: 240-253.